Viewing Study NCT06906900


Ignite Creation Date: 2025-12-26 @ 12:18 PM
Ignite Modification Date: 2026-01-01 @ 12:58 AM
Study NCT ID: NCT06906900
Status: RECRUITING
Last Update Posted: 2025-10-24
First Post: 2025-03-26
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase I Study of the NovoTTF-200M and Novo TTF-200A Systems for the Treatment of Refractory Spinal Metastasis
Sponsor: M.D. Anderson Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module